Transgenic animals
AssigneeGala Design, Inc.
InventorsRobert D. Bremel, Gregory T. Bleck
Life of this patent
Estimating the term…
Abstract
The present invention provides improved methods and compositions for the generation of transgenic non-human animals. The present invention permits the introduction of exogenous nucleic acid sequences into the genome of unfertilized eggs (e.g., pre-maturation oocytes and pre-fertilization oocytes) by microinjection of infectious retrovirus into the perivitelline space of the egg. The methods of the present invention provide an increased efficiency of production of transgenic animals with a reduced rate of generating animals which are mosaic for the presence of the transgene.
Claims53
A composition comprising a stably maintained recombinant mammalian zygote, wherein said zygote comprises a polynucleotide containing the proviral form of a retroviral vector integrated into the genome of said zygote.
A method for introducing a polynucleotide contained within the genome of a recombinant retrovirus into the genome of a mammalian zygote, comprising:
- a) providing:
- i) a mammalian zygote having a plasma membrane and a zona pellucida, said plasma membrane and said zona pellucida defining a perivitelline space;
- ii) an aqueous solution comprising a polynucleotide contained within the genome of a recombinant retrovirus;
- and
- b) introducing said solution comprising said polynucleotide contained within the genome of a recombinant retrovirus into said perivitelline space under conditions which permit the introduction of said polynucleotide contained within the genome of a recombinant retrovirus into the genome of said zygote, such that said polynucleotide is stably maintained.
A method for producing a transgenic non-human animal, wherein the genome of said transgenic non-human animal comprises a polynucleotide encoding a recombinant retrovirus and at least one protein of interest, comprising the steps of:
- a) providing:
- i) a non-human mammalian zygote having a plasma membrane and a zona pellucida, said plasma membrane and said zona pellucida defining a perivitelline space;
- ii) an aqueous solution comprising a polynucleotide contained within the genome of a recombinant retrovirus;
- b) introducing said solution comprising said polynucleotide contained within the genome of a recombinant retrovirus into said perivitelline space under conditions which permit the introduction of said polynucleotide contained within the genome of a recombinant retrovirus into the genome of said zygote, such that said polynucleotide is stably maintained in a recombinant zygote;
- c) transferring said recombinant zygote into a non-human female mammalian recipient that is hormonally synchronized to simulate early pregnancy, thereby giving a transferred embryo;
- d) allowing said transferred embryo to develop to term to produce a transgenic animal.
A method for expressing a protein of wherein said protein of interest is encoded by a polynucleotide contained within the genome of a recombinant retrovirus, comprising the steps of:
- a) providing:
- i) a non-human mammalian zygote having a plasma membrane and a zona pellucida, said plasma membrane and said zona pellucida defining a perivitelline space;
- ii) an aqueous solution comprising a polynucleotide encoding a protein of interest contained within the genome of a recombinant retrovirus;
- and
- b) introducing said solution comprising said polynucleotide encoding a protein of interest contained within the genome of a recombinant retrovirus into said perivitelline space under conditions which permit the introduction of said polynucleotide contained within the genome of a recombinant retrovirus into the genome of said zygote, such that said polynucleotide is stably maintained;
- c) allowing said zygote to develop into viable non-human animal, under conditions such that said protein of interest is expressed by said non-human animal.
A method for expressing a protein of interest wherein said protein of interest is encoded by a polynucleotide contained within the genome of a recombinant retrovirus, and said polynucleotide is integrated into the genome of a mammalian unfertilized oocyte, comprising the steps of:
- a) providing:
- i) an unfertilized mammalian egg comprising an oocyte having a plasma membrane and a zona pellucida, said plasma membrane and said zona pellucida defining a perivitelline space;
- ii) an aqueous solution containing recombinant retrovirus, wherein said recombinant retrovirus comprises a polynucleotide encoding a protein of interest;
- b) introducing said solution containing recombinant retrovirus into said perivitelline space under conditions which permit the infection of said oocyte to provide an infected oocyte;
- c) contacting said infected oocyte with sperm under conditions which permit the fertilization of said infected oocyte to produce an embryo;
- d) transferring said embryo into a hormonally synchronized mammalian recipient animal;
- e) allowing said embryo to develop into at least one viable transgenic mammalian animal, under conditions such that said protein of interest is expressed by said transgenic mammalian animal.
Dependencies are inferred from the claim text.